Atara Biotherapeutics (ATRA) EBITDA Margin Growth (3y) (2024 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 1,354.00 |
| 10 | Atara Biotherapeutics | 148.00 Mn | 131.45 Mn | 439,000.00 | 671,307.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 671,307.00 |
| Mar 31, 2026 | 546,602.00 |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | 179,428.00 |
| Jun 30, 2025 | 8,049.00 |
| Mar 31, 2025 | 124,571.00 |
| Dec 31, 2024 | 120,020.00 |
| Sep 30, 2024 | 152,523.00 |
| Jun 30, 2024 | 210,694.00 |
| Mar 31, 2024 | 208,862.00 |